PRKAA1 and Parkinson disease: et al., 2021), rotenone, 6-OHDA, paraquat, maneb induced and transgenic mouse PD model (Liu et al., 2019) but whether this drug acts via AMPK or PI3K/AKT is still unclear (Arbo et al., 2020).